The use of hyalomatrix PA in the treatment of extravasation affecting premature neonates

Plastic and Reconstructive Surgery

Volumn 129, Issue 1, 2012, Pages

  Onesti, Maria G ^a   Carella, Sara ^a   Maruccia, Michele ^a   Ciotti, Mariangela ^a   Scuderi, Nicolò ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID;

ARTIFICIAL SKIN; CONTRAST MEDIUM EXTRAVASATION; EDITORIAL; FEMALE; HUMAN; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; NEWBORN; PATHOLOGY; PREMATURITY; SKIN;

EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMANS; HYALURONIC ACID; INFANT, NEWBORN; INFANT, PREMATURE; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; MALE; SKIN; SKIN, ARTIFICIAL;

EID: 84555196604     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182365e16     Document Type: Note

References (5)

1. Wilkins CE, Emmerson AJ. Extravasation injuries on regional neonatal units. Arch Dis Child Fetal Neonatal Ed. 2004;89:F274-F275.
2. D'Andrea F, Onesti MG, Nicoletti GF, et al. Surgical treatment of ulcers caused by extravasation of cytotoxic drugs. Scand J Plast Reconstr Surg Hand Surg. 2004;38:288-292.
3. Gravante G, Sorge R, Merone A, et al. Hyalomatrix PA in burn care practice: Results from a national retrospective survey, 2005 to 2006. Ann Plast Surg. 2010;64:69-79.
4. Myers SR, Partha VN, Soranzo C, Price RD, Navsaria HA. Hyalomatrix: A temporary epidermal barrier, hyaluronan delivery, and neodermis induction system for keratinocyte stem cell therapy. Tissue Eng. 2007;13:2733-2741.
5. Gravante G, Delogu D, Giordan N, Morano G, Montone A, Esposito G. The use of Hyalomatrix PA in the treatment of deep partial-thickness burns. J Burn Care Res. 2007;28:269-274.